CF101
CF101 is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
8
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
77.8%
7 of 9 finished
22.2%
2 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Trial of CF101 to Treat Patients With Dry Eye Disease
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Clinical Trials (9)
Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Trial of CF101 to Treat Patients With Dry Eye Disease
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Trial of CF101 to Treat Patients With Psoriasis
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
Safety &Efficacy of CF101 to Subjects With Uveitis
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9